Alterity Therapeutics Net Debt Growth & History (ATHE)

Alterity Therapeutics's net debt was −$37.1M for fiscal 2026.

View full Alterity Therapeutics company overview

Alterity Therapeutics annual net debt history

Alterity Therapeutics annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20262026-06-30−$37.1M−$4.1M
20252025-06-30−$33.0M−$20.5M
20242024-06-30−$12.5M$3.1M
20232023-06-30−$15.6M$19.1M
20222022-06-30−$34.7M−$6.6M
20212021-06-30−$28.0M−$18.9M
20202020-06-30−$9.2M$5.1M
20192019-06-30−$14.3M

Alterity Therapeutics net debt trends

Over the last five fiscal years, Alterity Therapeutics's net debt decreased from −$28.0M to −$37.1M, a change of −$9.1M. The latest reported quarter, Q4 2026, shows −$37.1M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Alterity Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about ATHE yet. Start the conversation.

Write the first post